Trials / Recruiting
RecruitingNCT06612827
Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Centre Francois Baclesse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is based on the constitution of a collection of tumor and blood samples for the development of tumoroid for functional tests to predict clinical response to treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | organoid etablishment | Prior to initiation of 1st-line therapy: * Collection of an additional study-specific tumor sample for tumoroid analysis (1 fresh tumor sample) * A blood test blood a for tumoroid realization and : * Analysis of ex vivo tumoroid response to treatment and correlation with patient response in vivo * Analysis of correlation between in vivo and ex vivo tumor characteristics * Analysis of first- and second-line survival rates and overall survival |
Timeline
- Start date
- 2025-03-05
- Primary completion
- 2028-12-15
- Completion
- 2032-12-15
- First posted
- 2024-09-25
- Last updated
- 2025-12-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06612827. Inclusion in this directory is not an endorsement.